Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab: Editorial comment

Samir S. Taneja

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)809
Number of pages1
JournalJournal of Urology
Volume185
Issue number3
DOIs
StatePublished - Mar 2011

ASJC Scopus subject areas

  • Urology

Cite this